Surgery Partners, Inc. SGRY

14.40 0.20 1.41% as of 25 Sep
Market cap
$1.9B
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
3,308.70 3,114.30 2,743.30 2,539.30 2,225.10 1,860.10 1,831.40 1,771.50 1,341.20 1,145.44
Revenue Growth
6.24% 13.52% 8.03% 14.12% 19.62% 1.57% 3.38% 32.08% 17.09% 19.33%
Cost of Revenue
2,543.70 2,368.70 2,095.80 1,964.40 1,733.70 1,480.30 1,407.60 1,361.40 1,013.80 821.20
Gross Profit
765.00 745.60 647.50 574.90 491.40 379.80 423.80 410.10 327.40 324.24
SG&A Expenses
118.20 138.70 120.90 102.20 66.10 50.90 88.60 93.60 76.00 60.25
Operating Income
389.50 348.80 328.00 345.20 302.20 183.00 235.90 77.80 158.30 196.48
Non-operating Income/Expense
(272.60) (201.70) (193.00) (234.90) (221.00) (201.80) (181.30) (147.00) (76.00) (104.30)
Non-operating Interest Expenses
272.60 201.70 193.00 234.90 221.00 201.80 178.90 147.00 117.70 100.57
EBT
116.90 147.10 135.00 110.30 81.20 (18.80) 54.60 (69.20) 82.30 92.18
Income Tax Provision
18.00 134.60 (0.30) 23.30 10.50 (20.10) 9.50 26.40 53.60 7.10
Income after Tax
98.90 12.50 135.30 87.00 70.70 1.30 45.10 (95.60) 28.70 85.08
Dividends (Preferred)
— — 0.00 0.00 10.30 39.50 35.70 32.40 26.10 —
Non-Controlling Interest
176.80 180.60 147.20 141.60 141.60 117.40 119.90 110.10 81.70 75.63
Net Income Common
(77.90) (168.10) (11.90) (54.60) (81.20) (155.60) (110.50) (238.10) (79.10) 9.45
EPS (Basic)
(0.61) (1.33) (0.09) (0.59) (1.12) (3.19) (2.27) (4.96) (1.64) 0.20
EPS (Diluted)
(0.61) (1.33) (0.09) (0.59) (1.12) (3.19) (2.27) (4.96) (1.64) 0.20
Shares (Basic, Weighted)
127.21 126.12 125.61 91.95 72.43 48.78 48.28 48.03 48.32 48.02
Shares (Diluted, Weighted)
127.21 126.12 125.61 91.95 72.43 48.78 48.28 48.03 48.32 48.19
Gross Margin
23.12% 23.94% 23.60% 22.64% 22.08% 20.42% 23.14% 23.15% 24.41% 28.31%
EBIT Margin
12.46% 11.83% 12.47% 14.09% 14.09% 10.42% 13.44% 4.89% 12.28% 17.57%
EBT margin
3.53% 4.72% 4.92% 4.34% 3.65% (1.01%) 2.98% (3.91%) 6.14% 8.05%
Net Profit Margin
(2.35%) (5.40%) (0.43%) (2.15%) (3.65%) (8.37%) (6.03%) (13.44%) (5.90%) 0.83%
Free Cash Flow Margin
7.32% 6.82% 8.41% 3.59% 1.60% 14.11% 4.01% 7.00% 6.81% 7.52%
EBITDA
588.40 520.90 460.30 472.50 412.30 288.60 322.60 154.10 216.60 240.80
EBIT
412.40 368.30 342.20 357.70 313.50 193.80 246.10 86.70 164.70 201.25
Income from Continuous Operations
98.90 12.50 135.30 87.00 70.70 1.30 45.10 (95.60) 28.70 85.08
Consolidated Net Income/Loss
98.90 12.50 135.30 87.00 70.70 1.30 45.10 (95.60) 28.70 85.08
EPS (Basic, from Continuous Ops)
0.78 0.10 1.08 0.95 0.98 0.03 0.93 (1.99) 0.59 1.77
EPS (Basic, Consolidated)
0.78 0.10 1.08 0.95 0.98 0.03 0.93 (1.99) 0.59 1.77
EPS (Diluted, from Cont. Ops)
0.78 0.10 1.08 0.95 0.98 0.03 0.93 (1.99) 0.59 1.77
Shares (Diluted, Average)
127.21 126.12 125.61 91.95 72.43 48.78 48.28 48.03 48.19 48.19
EPS (Diluted, Consolidated)
0.78 0.10 1.08 0.95 0.98 0.03 0.93 (1.99) 0.59 1.77
EBITDA Margin
17.78% 16.73% 16.78% 18.61% 18.53% 15.52% 17.61% 8.70% 16.15% 21.02%
Operating Cash Flow Margin
8.29% 9.64% 10.71% 6.25% 3.91% 13.27% 7.07% 8.16% 9.01% 10.93%

Fold the line items

In millions of $ except per-share values · columns are period end dates